Immune checkpoint inhibitor-induced dyshidrotic eczema following tremelimumab therapy for hepatocellular carcinoma by Raphaella Lambert, BA, Scott Stratman, MD, Grace Rabinowitz, BA, Hannah Verma, BA, Jonas A. Adalsteinsson, MD, PhD, George Niedt, MD, Benjamin Ungar, MD, Nicholas Gulati, MD, PhD

Get full text